Market Overview:
The global cerebral folate deficiency market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of neurological disorders, rising awareness about the benefits of folate supplements, and growing demand for leucovorin calcium products. However, factors such as high cost of treatment and lack of reimbursement policies are restraining the growth of this market. The global cerebral folate deficiency market is segmented on the basis of type, application, and region. On the basis of type, it is divided into leucovorin calcium, folic acid, and folinic acid products. Leucovorin calcium dominates this market owing to its high efficacy in treating neurological disorders caused by deficiencies in folic acid or vitamin B12 levels. In terms on application, it is segmented into hospitals pharmacies clinics and other segments such as research laboratories etc.).
Product Definition:
Cerebral folate deficiency (CFD) is a rare neurological disorder caused by a lack of the vitamin folate. Folate is necessary for healthy brain function. A lack of folate can lead to problems with thinking, learning, and memory. CFD can also cause movement disorders, seizures, and coma.
Leucovorin Calcium:
Leucovorin calcium is a white crystalline compound, which is soluble in water and alcohol. It has a slight odor and taste. Leucovorin calcium can be manufactured synthetically as well as naturally. Synthetic form of the drug was first developed in Germany by Gerhard Domagk during the Second World War (1941). Natural leucovorin calcium can be extracted from bones of cattle, horses, humans, etc.
Folic Acid:
Folic acid or vitamin B9 is a form of water-soluble vitamin required by the body to manufacture red blood cells, and lack of it may lead to anemia. The normal level of folic acid in the human body is highly variable and dependent on various factors such as age, diet, lifestyle and other medical conditions. Folate deficiency may also occur when large doses are taken for long periods which can result in poor bone health, nerve damage or even death.
Application Insights:
The other application segment includes research studies and individualized medicine. Increasing the use of folinic acid in the treatment of spina bifida, anencephaly, and other neural tube defects is expected to drive market growth during the forecast period. In addition, increasing awareness about this deficiency among individuals suffering from these disorders is anticipated to fuel demand for this product over the forecast period.
In addition, growing usage of oral folic acid supplements for women who are pregnant or trying to become pregnant is expected to fuel demand over the next eight years.
Regional Analysis:
North America dominated the global cerebral folate deficiency market and accounted for the largest revenue share of 42.1% in 2017. This is due to high awareness levels about the product, presence of well-established healthcare facilities, and availability of a large patient pool with high disposable income in this region. Moreover, increasing prevalence of neurodegenerative disorders such as Alzheimer’s disease (AD) has further increased demand for these supplements in North America over the past few years. AD is one of the most common forms of dementia that impacts more than 5 million people in North America alone every year leading to significant economic burden on individuals as well as their families.
Growth Factors:
- Increasing awareness about Cerebral Folate Deficiency and its symptoms will drive the market growth.
- Rising incidence of neurological disorders will fuel the demand for Cerebral Folate Deficiency treatment drugs.
- Growing number of pregnant women suffering from folate deficiency will boost the Cerebral Folate Deficiency market growth.
- Increasing R&D investments for novel drug development will provide lucrative opportunities for market players in the near future.
- Technological advancements in diagnostic procedures and treatments options for cerebral folate deficiency will propel the cerebal folate deficiency market growth over the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Cerebral Folate Deficiency Market Research Report
By Type
Leucovorin Calcium, Folic Acid, Folinic Acid
By Application
Hospital, Pharmacy, Clinic, Other
By Companies
Pfizer, Hikma Pharmaceuticals, Eli Lilly and Company, Sagent Pharmaceuticals, Jiangsu Hengrui Medicine, Siemens Healthineers, GE Healthcare, Canon Medical Systems, Fonar Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
138
Number of Tables & Figures
97
Customization Available
Yes, the report can be customized as per your need.
Global Cerebral Folate Deficiency Market Report Segments:
The global Cerebral Folate Deficiency market is segmented on the basis of:
Types
Leucovorin Calcium, Folic Acid, Folinic Acid
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Hikma Pharmaceuticals
- Eli Lilly and Company
- Sagent Pharmaceuticals
- Jiangsu Hengrui Medicine
- Siemens Healthineers
- GE Healthcare
- Canon Medical Systems
- Fonar Corporation
Highlights of The Cerebral Folate Deficiency Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Leucovorin Calcium
- Folic Acid
- Folinic Acid
- By Application:
- Hospital
- Pharmacy
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cerebral Folate Deficiency Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cerebral folate deficiency is a condition in which the body does not produce enough of the vitamin folate. This can lead to problems with brain function, including poor memory and cognitive ability.
Some of the key players operating in the cerebral folate deficiency market are Pfizer, Hikma Pharmaceuticals, Eli Lilly and Company, Sagent Pharmaceuticals, Jiangsu Hengrui Medicine, Siemens Healthineers, GE Healthcare, Canon Medical Systems, Fonar Corporation.
The cerebral folate deficiency market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cerebral Folate Deficiency Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cerebral Folate Deficiency Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cerebral Folate Deficiency Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cerebral Folate Deficiency Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cerebral Folate Deficiency Market Size & Forecast, 2018-2028
4.5.1 Cerebral Folate Deficiency Market Size and Y-o-Y Growth
4.5.2 Cerebral Folate Deficiency Market Absolute $ Opportunity
Chapter 5 Global Cerebral Folate Deficiency Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cerebral Folate Deficiency Market Size Forecast by Type
5.2.1 Leucovorin Calcium
5.2.2 Folic Acid
5.2.3 Folinic Acid
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cerebral Folate Deficiency Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cerebral Folate Deficiency Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Clinic
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cerebral Folate Deficiency Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cerebral Folate Deficiency Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cerebral Folate Deficiency Analysis and Forecast
9.1 Introduction
9.2 North America Cerebral Folate Deficiency Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cerebral Folate Deficiency Market Size Forecast by Type
9.6.1 Leucovorin Calcium
9.6.2 Folic Acid
9.6.3 Folinic Acid
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cerebral Folate Deficiency Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.10.3 Clinic
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cerebral Folate Deficiency Analysis and Forecast
10.1 Introduction
10.2 Europe Cerebral Folate Deficiency Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cerebral Folate Deficiency Market Size Forecast by Type
10.6.1 Leucovorin Calcium
10.6.2 Folic Acid
10.6.3 Folinic Acid
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cerebral Folate Deficiency Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.10.3 Clinic
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cerebral Folate Deficiency Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cerebral Folate Deficiency Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cerebral Folate Deficiency Market Size Forecast by Type
11.6.1 Leucovorin Calcium
11.6.2 Folic Acid
11.6.3 Folinic Acid
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cerebral Folate Deficiency Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.10.3 Clinic
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cerebral Folate Deficiency Analysis and Forecast
12.1 Introduction
12.2 Latin America Cerebral Folate Deficiency Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cerebral Folate Deficiency Market Size Forecast by Type
12.6.1 Leucovorin Calcium
12.6.2 Folic Acid
12.6.3 Folinic Acid
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cerebral Folate Deficiency Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.10.3 Clinic
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cerebral Folate Deficiency Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cerebral Folate Deficiency Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cerebral Folate Deficiency Market Size Forecast by Type
13.6.1 Leucovorin Calcium
13.6.2 Folic Acid
13.6.3 Folinic Acid
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cerebral Folate Deficiency Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.10.3 Clinic
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cerebral Folate Deficiency Market: Competitive Dashboard
14.2 Global Cerebral Folate Deficiency Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Hikma Pharmaceuticals
14.3.3 Eli Lilly and Company
14.3.4 Sagent Pharmaceuticals
14.3.5 Jiangsu Hengrui Medicine
14.3.6 Siemens Healthineers
14.3.7 GE Healthcare
14.3.8 Canon Medical Systems
14.3.9 Fonar Corporation
